8017-3809 Screening compound: 1-{[7-(1H-1,2,3,4-tetraazol-1-yl)dibenzo[b,d]furan-2-yl]sulfonyl}indoline

8017-3809 Screening compound: 1-{[7-(1H-1,2,3,4-tetraazol-1-yl)dibenzo[b,d]furan-2-yl]sulfonyl}indoline
8017-3809 Screening compound: 1-{[7-(1H-1,2,3,4-tetraazol-1-yl)dibenzo[b,d]furan-2-yl]sulfonyl}indoline alternative view

Chemical Structure Depiction of ChemDiv screening compound 8017-3809
1-{[7-(1H-1,2,3,4-tetraazol-1-yl)dibenzo[b,d]furan-2-yl]sulfonyl}indoline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

8017-3809

Molecular Formula

C21H15N5O3S (C21 H15 N5 O3 S)

Compound Name

1-{[7-(1H-1,2,3,4-tetraazol-1-yl)dibenzo[b,d]furan-2-yl]sulfonyl}indoline

IUPAC name

1-{[11-(1H-1234-tetrazol-1-yl)-8-oxatricyclo[7.4.0.0^{27}]trideca-1(9)2461012-hexaen-4-yl]sulfonyl}-23-dihydro-1H-indole

SMILES

O=S(c(cc1)cc2c1oc1c2ccc(-n2nnnc2)c1)(N(CC1)c2c1cccc2)=O

InChI

InChI=1S/C21H15N5O3S/c27-30(28,26-10-9-14-3-1-2-4-19(14)26)16-6-8-20-18(12-16)17-7-5-15(11-21(17)29-20)25-13-22-23-24-25/h1-8,11-13H,9-10H2

InChI Key

MXUBRXZDMICXSO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD06016353

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

417.45

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.256

Distribution Coefficient, logD

4.256

Water Solubility, LogSw

-4.51

Polar Surface Area

79.437

Acid Dissociation Constant (pKa)

26.08

Base Dissociation Constant (pKb)

-4.36

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.50

8017-3809 in Drug Discovery

Included in Screening Libraries

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Nuclear receptors
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with 8017-3809 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 8017-3809?
Check Price and Availability of 8017-3809, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 8017-3809 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 8017-3809
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 8017-3809
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 8017-3809 available by request